menu search

XPH / Amgen to Buy Horizon Therapeutics: ETFs to Bet On

Amgen to Buy Horizon Therapeutics: ETFs to Bet On
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from the proposed deal. Read More
Posted: Dec 13 2022, 12:48
Author Name: Zacks Investment Research
Views: 111529

XPH News  

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

By Zacks Investment Research
September 18, 2023

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Car more_horizontal

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

By Zacks Investment Research
August 21, 2023

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively mana more_horizontal

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

By Zacks Investment Research
July 18, 2023

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Car more_horizontal

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive

By Seeking Alpha
July 16, 2023

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive more_horizontal

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

By Zacks Investment Research
June 21, 2023

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the SPDR S&P Pharmaceuticals ETF more_horizontal

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

By Zacks Investment Research
May 18, 2023

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Launched on 06/19/2006, the SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs ca more_horizontal

Pharma ETFs Gain Post Q1 Earnings

By Zacks Investment Research
May 9, 2023

Pharma ETFs Gain Post Q1 Earnings

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the more_horizontal

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

By Zacks Investment Research
April 21, 2023

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively mana more_horizontal


Search within

Pages Search Results: